Premium
Vemurafenib‐Induced Neutrophilic Panniculitis in a Child with a Brainstem Glioma
Author(s) -
West Emily S.,
Williams Victoria L.,
Morelli Joseph G.
Publication year - 2014
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.12316
Subject(s) - vemurafenib , medicine , panniculitis , dermatology , glioma , adverse effect , girl , brainstem , cancer research , cancer , metastatic melanoma , psychology , developmental psychology
Neutrophilic panniculitis is a rare adverse effect of therapy with selective BRAF inhibitors. We report a case of neutrophilic panniculitis in a 15‐year‐old girl receiving treatment with vemurafenib for a brainstem glioma. Clinicians should be aware of this rare but important side effect of vemurafenib. This is the first report of neutrophilic panniculitis in a child treated with vemurafenib.